REDMOND ASSET MANAGEMENT, LLC – Inhibikase Therapeutics, Inc. Transaction History
REDMOND ASSET MANAGEMENT, LLC portfolio value:
$111,000
portfolio value
REDMOND ASSET MANAGEMENT, LLC quarter portfolio value change:
+22.54%
quarter
Inhibikase Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.17% | -205 shares | 20K | $0.91 | 122.47K |
| Q2 2022 | share | 0.00% | 0 shares | -91K | $0.74 | 122.68K | |
| Q1 2022 | share | Increase | 0.00% | 122.68K shares | 182K | $1.48 | 122.68K |